Cervical cancer is the third most common cancer in women worldwide, with concepts and
knowledge about its prevention and treatment evolving rapidly. Human papillomavirus …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

This paper summarises the position of ESGO and EFC on cervical screening based on
existing guidelines and opinions of a team of lead experts. HPV test is replacing cytology as …

Objective Nine-valent human papillomavirus (9vHPV) vaccine efficacy against disease and
cervical surgeries related to all nine vaccine components was assessed compared with a …

Cervical cancer screening has enabled a decrease in the incidence and mortality of cervical
cancer. Various screening modalities have been studied to date. In many countries …

Aim Cervical cancer prevention guidelines include Human Papillomavirus (HPV) test,
cytology, and HPV-16/18 typing for triage to determine the risk of cervical intraepithelial …

Several randomized trials have demonstrated that HPV-based cervical cancer screening is
more effective than cytology-based screening. A pooled analysis of long-term follow-up data …

We monitored the burden of cancer in Italy and its trends over the last three decades,
providing estimates of cancer incidence, mortality, years of life lost, years lived with …

Introduction: The 9-valent human papillomavirus (9vHPV) vaccine covers the same HPV
types (6/11/16/18) as the quadrivalent HPV (qHPV) vaccine and 5 additional cancer-causing …